Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
Genoveva Uzunova, Former Senior Staff Associate at Columbia University in the City of New York, shared a post on LinkedIn:
“Today marks Sex Diff Day and Mental Health Awareness Week – a perfect time to discuss a gap in our healthcare system:
Sex as a Biological Variable (SABV).
As both a psychiatrist and a genetherapy researcher, I’ve seen how ignoring sex differences, from brain stereotaxic coordinates in the lab to diagnostic scales in the psychiatry clinic, may lead to missed targets and missed diagnoses.
In this video, I explore why men’s depression often ‘masks’ as irritability, and why structural brain differences mean we must move toward truly precision psychiatry.
We cannot provide better care until we do better, sex-specific science.
We know that the brains of female mice have many neuroanatomical and gene expression differences with the brains of male mice, which may translate into different behaviors.
Diseases such as depression, anxiety, autism, Alzheimer’s disease, multiple sclerosis, Systemic lupus erythematosus (SLE), and breast cancer have higher rates in women than in men.
In connection with today, my dear Mom, Anelia Uzunova, published a letter in Nature in 1976 with her co-authors Estelle Ramey and Peter Ramwell, on the Effect of testosterone, sex and age on experimentally induced arterial thrombosis.
My views in this presentation are based on my professional experience and literature searches.
I have discussed many of them, particularly relating to gene therapy and depression, with my supervisors but have met with some resistance as this will complicate the studies and work.
When I researched brain gene therapies for neurodegenerative disorders, I measured the Bregma-Lambda distances in our four transgenic mouse strains and found differences between strains and males and females.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering